Selective intermediate‐/small‐conductance calcium‐activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma
- 14 September 2004
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 20 (7), 1761-1768
- https://doi.org/10.1111/j.1460-9568.2004.03615.x
Abstract
Early deterioration and death after brain injury is often the result of oedema in the injured and peri-lesional tissue. So far, no pharmacotherapy is available that exhibits significant brain oedema-reducing efficacy in patients. We selected two low molecular weight compounds from different chemical classes, a triazole (1-[(2-chlorophenyl)diphenylmethyl]-1,2,3-triazole) and a cyclohexadiene (methyl 4-[4-chloro-3-(trifluoromethyl)phenyl]-6-methyl-3-oxo-1,4,7-tetrahydroisobenzofuran-5-carboxylate) to characterize their pharmacological properties on KCNN4 channels (intermediate/small conductance calcium-activated potassium channel, subfamily N, member 4) in vitro as well as in vivo. In vitro we replaced potassium by rubidium (Rb+) and determined Rb+ fluxes evoked by 10 micro m of the calcium ionophore A23187 on C6BU1 rat glioma cells. Compared with known KCNN4 blockers, such as clotrimazole (IC50=360 +/- 12 nm) and charybdotoxin (IC50=3.3 +/- 1.9 nm), the triazole and cyclohexadiene were considerably more potent than clotrimazole and displayed similar potencies (IC50=12.1 +/- 8.8 and 13.3 +/- 4.7 nm, respectively). In the rat acute subdural haematoma model, both the triazole and cyclohexadiene displayed reduction of brain water content (-26% at 0.3 mg/kg and -24% at 0.01 mg/kg) and reduction of the intracranial pressure (-46% at 0.1 mg/kg and -60% at 0.003 mg/kg) after 24 h when administered as a 4-h infusion immediately after brain injury. When infarct volumes were determined after 7 days, the triazole as well as the cyclohexadiene displayed strong neuroprotective efficacy (-52% infarct volume reduction at 1.2 mg/kg and -43% at 0.04 mg/kg, respectively). It is concluded that blockade of KCNN4 channels is a new pharmacological approach to attenuate acute brain damage caused by traumatic brain injury.Keywords
This publication has 37 references indexed in Scilit:
- Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microgliaNeuropharmacology, 2003
- 4-Phenyl-4H-pyrans as IKCa channel blockersBioorganic & Medicinal Chemistry Letters, 2003
- Bench to Bedside: Brain Edema and Cerebral Resuscitation: The Present and FutureAcademic Emergency Medicine, 2002
- The Effect of Treatment with Albumin, Hetastarch, or Hypertonic Saline on Neurological Status and Brain Edema in a Rat Model of Closed Head Trauma Combined with Uncontrolled Hemorrhage and Concurrent Resuscitation in RatsAnesthesia & Analgesia, 2001
- The Effect of Treatment with Albumin, Hetastarch, or Hypertonic Saline on Neurological Status and Brain Edema in a Rat Model of Closed Head Trauma Combined with Uncontrolled Hemorrhage and Concurrent Resuscitation in RatsAnesthesia & Analgesia, 2001
- Neuroprotective effects of citicoline on brain edema and blood—brain barrier breakdown after traumatic brain injuryJournal of Neurosurgery, 2000
- ICP Monitoring in the Rat: Comparison of Monitoring in the Ventricle, Brain Parenchyma, and Cisterna MagnaJournal of Neurotrauma, 1999
- Effects of the Novel NMDA Antagonists CP-98,113, CP-101,581 and CP-101,606 on Cognitive Function and Regional Cerebral Edema Following Experimental Brain Injury in the RatJournal of Neurotrauma, 1997
- Presence of a charybdotoxin sensitive Ca2+-activated K+ channel in rat glioma C6 cellsNeuroscience Letters, 1988
- The function of calcium in the potassium permeability of human erythrocytesBiochimica et Biophysica Acta, 1958